Assessing the role of primary healthy microglia and gap junction blocker in hindering Alzheimer's disease neuroinflammatory type: Early approaches for therapeutic intervention.

Anwar, Mai M; Özkan, Esra; Shomalizadeh, Narges; Sapanci, Selin; Özler, Ceyda; Kesibi, Judy; Gürsoy-Özdemir, Yasemin

Anwar, Mai M; Özkan, Esra; Shomalizadeh, Narges; Sapanci, Selin; Özler, Ceyda; Kesibi, Judy; Gürsoy-Özdemir, Yasemin.

Afiliación

Anwar MM; Department of Biochemistry, National Organization for Drug Control and Research/Egyptian Drug Authority, Cairo, Egypt.
Özkan E; Koç University Research Center for Translational Medicine, KUTTAM, Koç University, Istanbul, Turkey.
Shomalizadeh N; Koç University Research Center for Translational Medicine, KUTTAM, Koç University, Istanbul, Turkey.
Sapanci S; Koç University Research Center for Translational Medicine, KUTTAM, Koç University, Istanbul, Turkey.
Özler C; Koç University Research Center for Translational Medicine, KUTTAM, Koç University, Istanbul, Turkey.
Kesibi J; Koç University Research Center for Translational Medicine, KUTTAM, Koç University, Istanbul, Turkey.
Gürsoy-Özdemir Y; Koç University Research Center for Translational Medicine, KUTTAM, Koç University, Istanbul, Turkey.

Front Neurosci ; 16: 1041461, 2022.

Article en En | MEDLINE | ID: mdl-36704003

Palabras clave

Alzheimer's disease; Aß; CBX; ICV; healthy microglia; inflammation; microgliosis; tau protein

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: Front Neurosci Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google